Lee Danner & Bass Inc. Has $2.48 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Lee Danner & Bass Inc. grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 32.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,185 shares of the company's stock after purchasing an additional 8,870 shares during the quarter. Lee Danner & Bass Inc.'s holdings in Henry Schein were worth $2,478,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Deroy & Devereaux Private Investment Counsel Inc. increased its position in Henry Schein by 2.9% during the first quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 48,940 shares of the company's stock worth $3,352,000 after acquiring an additional 1,390 shares during the period. IFM Investors Pty Ltd increased its position in Henry Schein by 6.6% during the first quarter. IFM Investors Pty Ltd now owns 23,831 shares of the company's stock worth $1,737,000 after acquiring an additional 1,482 shares during the period. OneDigital Investment Advisors LLC increased its position in Henry Schein by 22.5% during the first quarter. OneDigital Investment Advisors LLC now owns 4,917 shares of the company's stock worth $337,000 after acquiring an additional 903 shares during the period. Palisade Capital Management LP increased its position in Henry Schein by 16.7% during the first quarter. Palisade Capital Management LP now owns 44,163 shares of the company's stock worth $3,025,000 after acquiring an additional 6,304 shares during the period. Finally, Teacher Retirement System of Texas bought a new stake in Henry Schein in the 1st quarter valued at $3,293,000. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 0.3%

Shares of HSIC traded up $0.21 during mid-day trading on Wednesday, hitting $74.16. 763,827 shares of the company's stock were exchanged, compared to its average volume of 1,720,221. The company has a market cap of $9.03 billion, a PE ratio of 23.18, a P/E/G ratio of 2.37 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a 50-day simple moving average of $71.01 and a 200 day simple moving average of $71.25. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the business earned $1.10 earnings per share. The firm's revenue was down .1% on a year-over-year basis. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HSIC shares. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research lowered their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Evercore ISI upped their target price on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a report on Wednesday. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus target price of $79.70.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.